A case of markedly impaired wound repair with angiostatic pazopanib in a patient who had Mohs surgery for a basal cell carcinoma

A case of markedly impaired wound repair with angiostatic pazopanib in a patient who had Mohs surgery for a basal cell carcinoma

This case report highlights the adverse effects of pazopanib, a vascular endothelial growth factor receptor inhibitor, on wound healing after Mohs surgery. A 79-year-old male with metastatic renal cell carcinoma of the lung, on 600 mg daily pazopanib, underwent Mohs surgery for a nodular basal cell...

Full description

Bibliographic Details
Main Authors: William J Nahm, Gail de Imus, Christopher A Mathe, Liliana Saap, Saiyan Joseph, Stanley Chen, Vincent Falanga
Format: Article
Language:English
Published: SAGE Publishing 2023-09-01
Series:SAGE Open Medical Case Reports
Online Access:https://doi.org/10.1177/2050313X231200967

Internet

https://doi.org/10.1177/2050313X231200967

Similar Items